Share

Omega

Project objectives

Evaluation of the safety and performance of the left atrial occlusion device (Omega) in patients with non-valvular atrial fibrillation and high risk of hemorrhage

Start and end date

May 2022 - ongoing
Approximate end December 2023

Project Manager

Prof. Gian Paolo Ussia

Coordinating institution of the project

Eclipse Medical Ltd.
magnifiercrossmenuchevron-downchevron-leftchevron-right